Seroprevalence of hepatitis C virus antigen in patients with chronic liver disease and hepatocellular carcinoma at 12(th) week of treatment: a cross-sectional study

INTRODUCTION: epidemiological data suggests that more than 50% of hepatitis C virus (HCV) patients fail treatment. The objective of the study was to highlight the seroprevalence of hepatitis C virus antigen (HCV Ag) at the 12(th) week of treatment. METHODS: during a cross-sectional study, participan...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbaga, Donatien Serge, Bikoï, Jacky Njiki, Okobalemba, Etienne Atenguena, Essindi, Justin Olivier, Mikangue, Chris André Mbongue, Membangbi, Alexandra Emmanuelle, Ngoutane, Aïcha, Elang, Arnaud Franck, Touangnou-Chamda, Sabine Aimée, Sake, Carole Stéphanie, Mondinde, George Ikomey, Kenmoe, Sebastien, Essama, Sara Honorine Riwom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789782/
https://www.ncbi.nlm.nih.gov/pubmed/36590993
http://dx.doi.org/10.11604/pamj.2022.43.72.35450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789782/
https://www.ncbi.nlm.nih.gov/pubmed/36590993
http://dx.doi.org/10.11604/pamj.2022.43.72.35450

Ejemplares similares